Amundi 13F: Adds $137M to Baker Hughes (BKR) Stake
Amundi has boosted its position in Baker Hughes Company by approximately 2.4 million shares.
Reviewed by automated data checks against the source filing. How we make and check alerts
Amundi added 2,409,978 shares to its stake in Baker Hughes Company ($BKR), a 28.23% increase, according to a 13F filing with the SEC dated May 18, 2026. It reported 10,946,464 shares worth $620.45 million at the end of the quarter.
Since the filing, $BKR is up 0.8% after 1 week, down 9.3% after 1 month and down 15.6% to date (from the $65.97 close on May 18, 2026).
BKR
Baker Hughes Company
Key Points
- Amundi added about 2.41 million shares of Baker Hughes Company, growing its total stake to around 10.9 million shares valued at approximately $620.4 million as of May 18, 2026.
- Amundi held 10,946,464 $BKR shares at quarter end, up 28.23% from the prior quarter.
- Baker Hughes trades at $56.68, which is below its 52-week high of $70.41, suggesting potential for growth.
- Analysts have a consensus 'buy' rating on Baker Hughes, with a mean price target of $72.30 based on 23 opinions.
Get $BKR trade alerts by text
We text you when insiders, Congress or big funds trade $BKR. Free.
Not investment advice. EarningsIQ is not a registered investment adviser, and this automated Baker Hughes Company alert may contain errors. Disclosures
Amundi Boosts Position in Baker Hughes Company
Amundi has increased its stake in Baker Hughes Company (BKR) by about 2.41 million shares, bringing its total holdings to around 10.9 million shares valued at approximately $620.4 million. This change reflects the fund's confidence in the company as of May 18, 2026, according to the latest Form 13F filing with the SEC.
What's New in Amundi's Position
This increase represents a 28.2% boost in Amundi's position in Baker Hughes. The fund previously held about 8.54 million shares before this addition, which shows a significant commitment to the energy sector.
Institutional Activity
While no other funds reported changes in their Baker Hughes holdings in this filing, Amundi's decision stands out given its sizable increase in shares. This kind of movement often signals confidence in a company's future performance.
Stock Performance and Market Context
Baker Hughes shares are currently trading at $56.68, which is below the company's 52-week high of $70.41. This suggests that the stock may be undervalued relative to its potential, especially as it has been fluctuating around this key price point. The company has a market cap of approximately $57.4 billion and a P/E ratio of 18.59, indicating a reasonable valuation in the energy sector.
Recent Earnings
Baker Hughes reported revenue of approximately $27.73 billion, with a net margin of about 11.17%. The company is expected to announce its next earnings report on October 22, 2026, which will provide further insights into its financial health.
Earnings drift grade
Outlook vs expectations on the last report — not price action.
-
Forward outlook
10 analysts raised price targets.
-
EPS & revenue
EPS beat estimates by 16.2%. Revenue beat estimates by 3.0%.
-
Profit surprise
EBITDA beat by 11 percent. Operating income beat by 8 percent.
-
Pre-earnings setup
Bar was high, analysts already very bullish.
-
Analyst signal
1 downgrade, 10 target raises.
-
Earnings quality
Operating margin up 0.6 points. Positive free cash flow.
Earnings Call Summary
Baker Hughes delivered a strong first quarter with adjusted earnings per share of $0.58, beating expectations of $0.50. Energy infrastructure orders hit a record $4.9 billion, driven by data center power demand and liquefied natural gas projects. The Middle East conflict caused some disruption but strong performance elsewhere, particularly in power systems and gas compression, more than offset those challenges.
Guidance Baker Hughes reaffirmed its full year revenue and earnings targets. They expect about $6.5 billion in second quarter revenue and $1.13 billion in adjusted EBITDA. Management assumes the Middle East conflict continues through June, then gradually improves in the second half of the year.
Good report. The company beat and showed some forward improvement, with a few meaningful caveats.
Insider Buying and Selling at Baker Hughes Company
On June 12, 2026, Lorenzo Simonelli, the Chairman, President, and CEO of Baker Hughes, sold 181,411 shares at an average price of $63.36, totaling about $11.49 million. This transaction was part of a planned selling strategy and does not indicate any negative outlook for the company.
Analysts Set New Price Targets
Analysts maintain a generally positive outlook for Baker Hughes. On September 30, 2026, UBS kept a 'Neutral' rating with a price target of $69.00, down from $72.00. Jefferies also maintained a 'Buy' rating with a target of $77.00, reduced from $80.00. The average price target across 23 opinions is $72.30, reflecting a consensus 'buy' recommendation.
What Baker Hughes Company Does
Baker Hughes Company provides a range of technologies and services for the energy and industrial sectors. This includes equipment and services for oil and gas operations, as well as various industrial applications. Amundi's increased stake highlights its belief in Baker Hughes' growth potential in these markets.
What's Ahead for Baker Hughes Company
Investors will be watching Baker Hughes closely as it prepares for its next earnings report on October 22, 2026. The recent 13F filing reflects positions as of the reporting period and may not represent current holdings. Amundi's significant stake in Baker Hughes could influence market perception moving forward.
Related Filing Alerts
Source: Amundi's 13F filing on $BKR (May 18, 2026). 13F filings show holdings as of the end of the reporting quarter and may not reflect the fund's current position. Find the original filing: Amundi 13F filings on SEC EDGAR. Written by software, not financial advice. How we make alerts